Funding for qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies.

Main Caractheristics

CLIP Grants provide funding for qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grant will support basic, pre-clinical, and translational research, which will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic.

PROGRAM UPDATE

CRI has obtained designated funding that will provide for a limited number of additional CLIP grants focused on topics related to biomarkers, including such topics as tumor mutational burden, microbiome, host genomic factors, and others. Proposals in this area are encouraged.

Requirements

Candidates for a CLIP Grant must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation.

CRI has no citizenship restrictions, and research supported by the award may be conducted at medical schools and research centers in the United States or abroad.
Please note that CLIP Grants do not support research at for-profit institutions

Duration

2 years

Funding

100.000 $ /year

Documentation

Letters of intent must be submitted electronically at https://www.grantrequest.com/SID_205?SA=SNA&FID=35012

Supporting documentation:

-Abstract of research in nontechnical English explaining the importance of the proposed research and its clinical relevance. Not to exceed 250 words.

- An initial research concept (succinct description of the proposed research, description of the relevance of the proposed research to cancer immunology, description of how your proposed project bridges laboratory and clinical discovery), not to exceed 3 pages.

- Brief description of your current research.

- Curriculum vitae and bibliography (limit bibliography to past 5 years or publications relevant to proposed research)

Deadline

In case of interest, please contact with Research Management Department until 25th October 2020.